Metabolic landscape of the tumor microenvironment at single cell resolution

The tumor milieu consists of numerous cell types each existing in a different environment. However, a characterization of metabolic heterogeneity at single-cell resolution is not established. Here, we develop a computational pipeline to study metabolic programs in single cells. In two representative human cancers, melanoma and head and neck, we apply this algorithm to define the intratumor metabolic landscape. We report an overall discordance between analyses of single cells and those of bulk tumors with higher metabolic activity in malignant cells than previously appreciated. Variation in mitochondrial programs is found to be the major contributor to metabolic heterogeneity. Surprisingly, the expression of both glycolytic and mitochondrial programs strongly correlates with hypoxia in all cell types. Immune and stromal cells could also be distinguished by their metabolic features. Taken together this analysis establishes a computational framework for characterizing metabolism using single cell expression data and defines principles of the tumor microenvironment. Each cell type in the tumour microenvironment has unique metabolic demands enabling specific functions. Here the authors use published single-cell RNA-seq data and develop a computational framework to better understand the heterogeneity of tumour metabolism, highlighting the discordance between results obtained from single cells and bulk tumours.

[1]  Fergus Gleeson,et al.  Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast Cancer , 2018, Cell metabolism.

[2]  Wei Vivian Li,et al.  An accurate and robust imputation method scImpute for single-cell RNA-seq data , 2018, Nature Communications.

[3]  S. Andò,et al.  Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: Connecting TGF-β signaling with “Warburg-like” cancer metabolism and L-lactate production , 2012, Cell cycle.

[4]  M. Bergmann,et al.  Exploring Metabolic Configurations of Single Cells within Complex Tissue Microenvironments. , 2017, Cell metabolism.

[5]  Matthew G. Vander Heiden,et al.  Understanding the Intersections between Metabolism and Cancer Biology , 2017, Cell.

[6]  Neil Swainston,et al.  Improving metabolic flux predictions using absolute gene expression data , 2012, BMC Systems Biology.

[7]  J. Marioni,et al.  Pooling across cells to normalize single-cell RNA sequencing data with many zero counts , 2016, Genome Biology.

[8]  J. Moscat,et al.  Metabolism shapes the tumor microenvironment. , 2017, Current opinion in cell biology.

[9]  Andrea Glasauer,et al.  Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis , 2014, eLife.

[10]  Mariella G. Filbin,et al.  Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq , 2017, Science.

[11]  Sandrine Dudoit,et al.  Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments , 2010, BMC Bioinformatics.

[12]  C. Funk,et al.  Prostaglandins and leukotrienes: advances in eicosanoid biology. , 2001, Science.

[13]  P. Schumacker,et al.  Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. , 2005, Cell metabolism.

[14]  M. Simon,et al.  Oxygen availability and metabolic adaptations , 2016, Nature Reviews Cancer.

[15]  Christian Frezza,et al.  Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival , 2016, Nature Communications.

[16]  Jeong Eon Lee,et al.  Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer , 2017, Nature Communications.

[17]  Peter Carmeliet,et al.  Metabolism of stromal and immune cells in health and disease , 2014, Nature.

[18]  R. Deberardinis,et al.  Metabolic pathways promoting cancer cell survival and growth , 2015, Nature Cell Biology.

[19]  Ji Luo,et al.  NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis , 2016, Nature.

[20]  D. Wallace,et al.  Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments. , 2017, Cell metabolism.

[21]  J. Rathmell,et al.  Metabolic pathways in T cell fate and function. , 2012, Trends in immunology.

[22]  A. Kimmelman,et al.  Metabolic Interactions in the Tumor Microenvironment. , 2017, Trends in cell biology.

[23]  D. Fearon,et al.  T cell exclusion, immune privilege, and the tumor microenvironment , 2015, Science.

[24]  Charles H. Yoon,et al.  Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq , 2016, Science.

[25]  J. Locasale,et al.  The Warburg Effect: How Does it Benefit Cancer Cells? , 2016, Trends in biochemical sciences.

[26]  D. Vitkup,et al.  Heterogeneity of tumor-induced gene expression changes in the human metabolic network , 2013, Nature Biotechnology.

[27]  C. Thompson,et al.  Nutrient acquisition strategies of mammalian cells , 2017, Nature.

[28]  Martin L. Miller,et al.  Mitochondrial DNA copy number variation across human cancers , 2015, bioRxiv.

[29]  J. Mi,et al.  Metabolic reprogramming of cancer-associated fibroblasts by IDH3α downregulation. , 2015, Cell reports.

[30]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[31]  Shawn M. Gillespie,et al.  Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer , 2017, Cell.

[32]  M. Haigis,et al.  Mitochondria and Cancer , 2016, Cell.

[33]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[35]  R. Gillies,et al.  Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.

[36]  R. Kalluri The biology and function of fibroblasts in cancer , 2016, Nature Reviews Cancer.

[37]  J. Locasale,et al.  Characterization of the usage of the serine metabolic network in human cancer. , 2014, Cell reports.

[38]  Geoffrey E. Hinton,et al.  Visualizing Data using t-SNE , 2008 .

[39]  C. Curtis,et al.  A Big Bang model of human colorectal tumor growth , 2015, Nature Genetics.

[40]  Shawn M. Gillespie,et al.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.

[41]  Michael D. Buck,et al.  Metabolic Instruction of Immunity , 2017, Cell.

[42]  C. Sander,et al.  Mitochondrial respiratory gene expression is suppressed in many cancers , 2016, eLife.

[43]  C. Sander,et al.  A Landscape of Metabolic Variation across Tumor Types. , 2018, Cell systems.

[44]  Davis J. McCarthy,et al.  A step-by-step workflow for low-level analysis of single-cell RNA-seq data with Bioconductor , 2016, F1000Research.

[45]  Navdeep S. Chandel,et al.  Fundamentals of cancer metabolism , 2016, Science Advances.

[46]  J. Xavier,et al.  Metabolic origins of spatial organization in the tumor microenvironment , 2017, Proceedings of the National Academy of Sciences.

[47]  Jinzhou Yuan,et al.  Single-Cell Transcriptomic Analysis of Tumor Heterogeneity. , 2018, Trends in cancer.

[48]  Zhongming Zhao,et al.  Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers , 2018, Cell reports.

[49]  B. Garcia,et al.  Acetate Production from Glucose and Coupling to Mitochondrial Metabolism in Mammals , 2018, Cell.

[50]  W. Huber,et al.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .

[51]  Joshua M. Stuart,et al.  The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.

[52]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[53]  E. Lengyel,et al.  Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis. , 2019, Cell metabolism.

[54]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of head and neck squamous cell carcinomas , 2015, Nature.

[55]  Chris Sander,et al.  An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma. , 2016, Cancer cell.

[56]  J. Riley,et al.  Translating In Vitro T Cell Metabolic Findings to In Vivo Tumor Models of Nutrient Competition. , 2018, Cell metabolism.

[57]  J. Rathmell,et al.  Similarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors. , 2017, Cell metabolism.

[58]  E. Lengyel,et al.  Metformin Targets Central Carbon Metabolism and Reveals Mitochondrial Requirements in Human Cancers. , 2016, Cell metabolism.

[59]  J. Rathmell,et al.  Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets , 2011, The Journal of Immunology.

[60]  P. Carmeliet,et al.  Endothelial Cell Metabolism in Health and Disease. , 2017, Trends in cell biology.

[61]  Adam A. Margolin,et al.  The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.

[62]  Jeff S. Jasper,et al.  ERRα-Regulated Lactate Metabolism Contributes to Resistance to Targeted Therapies in Breast Cancer. , 2016, Cell reports.

[63]  C. Thompson,et al.  The Emerging Hallmarks of Cancer Metabolism. , 2016, Cell metabolism.

[64]  T. Nomura,et al.  Regulatory T Cells and Immune Tolerance , 2008, Cell.